Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Value of Copeptin Level Before Cardiac Surgery and Involvement in Systemic Inflammatory Response Syndrome After Cardiopulmonary Bypass

NCT03288610 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT03288610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03288610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Value of Copeptin Level Before Cardiac Surgery and Involvement in Systemic Inflammatory Response Syndrome After Cardiopulmonary Bypass
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Completed
Start date
January 31, 2017
Completion date
August 31, 2017
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac surgery prognosis, postoperative vasodilation syndrome, stress response, systemic inflammatory response syndrome (sirs), tissue oxygenation and post-ischemic response